Showing results (321-330 of 420) with videos related to
Sort By:
Pageof 42
Hinyokika Kiyo. Acta Urologica Japonica|August 1, 1988
[Clinical study on the effect of CSF-HU (colony stimulating factor human urine) on leukopenia and granulocytopenia induced by cancer chemotherapy--a double-blind study in patients with genito-urinary cancer]T Niijima, Y Aso, H Akaza, et al.Hinyokika Kiyo. Acta Urologica Japonica|April 1, 1991
[Comparative study of cefpirome and ceftazidime in complicated urinary tract infections]Y Naide, Y Aso, M Oshi, et al.The Journal of Urology|November 1, 1991
Deoxyribonucleic acid and cytological detection of Y-containing cells in an XX hypospadiac boy with polyorchidismM Yoshida, Y Kakizawa, N Moriyama, et al.Hinyokika Kiyo. Acta Urologica Japonica|April 1, 1993
[Phase I study of flutamide, a nonsteroidal antiandrogen, in patients with prostatic cancer]Y Aso, H Akaza, K Koiso, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 1987
[Antiemetic effects of MS-5080 associated with cisplatin chemotherapy--an attempt in assessment based on the sample score system using multivariate analysis]T Niijima, Y Aso, H Akaza, et al.Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|October 1, 1990
[Histological effects of endocrine therapy on prostatic cancer]S Isaka, K Akakura, J Shimazaki, et al.Journal of Interpersonal Violence|May 4, 2022
Patterns of Intimate Partner Violence and the Harsh Parenting of ChildrenAshley N Rousson, Emiko A Tajima, Todd I Herrenkohl, et al.The American Journal of Orthopsychiatry|October 14, 2015
Labeling and the effect of adolescent legal system involvement on adult outcomes for foster youth aging out of careJoAnn S Lee, Mark E Courtney, Tracy W Harachi, et al.Journal of Applied Microbiology|October 7, 2011
Cloning, expression and purification of extracellular serine protease Esp, a biofilm-degrading enzyme, from Staphylococcus epidermidisS Sugimoto, T Iwase, F Sato, et al.Hinyokika Kiyo. Acta Urologica Japonica|April 1, 1993
[Clinical evaluation of flutamide, a pure antiandrogen, in prostatic cancer phase II dose-finding study]Y Aso, H Akaza, K Koiso, et al.Pageof 42